Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
DOI: | 10.20945/2359-3997000000114 |
Texto Completo: | http://dx.doi.org/10.20945/2359-3997000000114 http://hdl.handle.net/11449/187698 |
Resumo: | Objective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line. |
id |
UNSP_e3e16967d8bff2e6a4963c8a8a613e69 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/187698 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7Breast cancerGene expressionNongenomic actionsThyroid hormoneObjective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Departamento de Medicina Interna Faculdade de Medicina de Botucatu Universidade Estadual Paulista (UNESP)Universidade Estadual Paulista (UNESP)Departamento de Fisiologia e Biofísica Instituto de Ciencias Biomédicas Universidade de São Paulo (USP)Departamento de Medicina Interna Faculdade de Medicina de Botucatu Universidade Estadual Paulista (UNESP)Universidade Estadual Paulista (UNESP)FAPESP: 2013/05629-4FAPESP: 2014/15209-5FAPESP: 2015/09686-8Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Silva, Tabata M. [UNESP]Moretto, Fernanda C. F. [UNESP]De Sibio, Maria T. [UNESP]Gonçalves, Bianca M. [UNESP]Oliveira, Miriane [UNESP]Olimpio, Regiane M. C. [UNESP]Oliveira, Diego A. M. [UNESP]Costa, Sarah M. B. [UNESP]Deprá, Igor C. [UNESP]Namba, Vickeline [UNESP]Nunes, Maria T.Nogueira, Célia R. [UNESP]2019-10-06T15:44:33Z2019-10-06T15:44:33Z2019-05-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article142-147application/pdfhttp://dx.doi.org/10.20945/2359-3997000000114Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019.2359-42922359-3997http://hdl.handle.net/11449/18769810.20945/2359-3997000000114S2359-399720190002001422-s2.0-85066163660S2359-39972019000200142.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengArchives of Endocrinology and Metabolisminfo:eu-repo/semantics/openAccess2023-11-02T06:11:00Zoai:repositorio.unesp.br:11449/187698Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T16:43:54.224053Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
title |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
spellingShingle |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 Silva, Tabata M. [UNESP] Breast cancer Gene expression Nongenomic actions Thyroid hormone Silva, Tabata M. [UNESP] Breast cancer Gene expression Nongenomic actions Thyroid hormone |
title_short |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
title_full |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
title_fullStr |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
title_full_unstemmed |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
title_sort |
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7 |
author |
Silva, Tabata M. [UNESP] |
author_facet |
Silva, Tabata M. [UNESP] Silva, Tabata M. [UNESP] Moretto, Fernanda C. F. [UNESP] De Sibio, Maria T. [UNESP] Gonçalves, Bianca M. [UNESP] Oliveira, Miriane [UNESP] Olimpio, Regiane M. C. [UNESP] Oliveira, Diego A. M. [UNESP] Costa, Sarah M. B. [UNESP] Deprá, Igor C. [UNESP] Namba, Vickeline [UNESP] Nunes, Maria T. Nogueira, Célia R. [UNESP] Moretto, Fernanda C. F. [UNESP] De Sibio, Maria T. [UNESP] Gonçalves, Bianca M. [UNESP] Oliveira, Miriane [UNESP] Olimpio, Regiane M. C. [UNESP] Oliveira, Diego A. M. [UNESP] Costa, Sarah M. B. [UNESP] Deprá, Igor C. [UNESP] Namba, Vickeline [UNESP] Nunes, Maria T. Nogueira, Célia R. [UNESP] |
author_role |
author |
author2 |
Moretto, Fernanda C. F. [UNESP] De Sibio, Maria T. [UNESP] Gonçalves, Bianca M. [UNESP] Oliveira, Miriane [UNESP] Olimpio, Regiane M. C. [UNESP] Oliveira, Diego A. M. [UNESP] Costa, Sarah M. B. [UNESP] Deprá, Igor C. [UNESP] Namba, Vickeline [UNESP] Nunes, Maria T. Nogueira, Célia R. [UNESP] |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Silva, Tabata M. [UNESP] Moretto, Fernanda C. F. [UNESP] De Sibio, Maria T. [UNESP] Gonçalves, Bianca M. [UNESP] Oliveira, Miriane [UNESP] Olimpio, Regiane M. C. [UNESP] Oliveira, Diego A. M. [UNESP] Costa, Sarah M. B. [UNESP] Deprá, Igor C. [UNESP] Namba, Vickeline [UNESP] Nunes, Maria T. Nogueira, Célia R. [UNESP] |
dc.subject.por.fl_str_mv |
Breast cancer Gene expression Nongenomic actions Thyroid hormone |
topic |
Breast cancer Gene expression Nongenomic actions Thyroid hormone |
description |
Objective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-06T15:44:33Z 2019-10-06T15:44:33Z 2019-05-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.20945/2359-3997000000114 Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019. 2359-4292 2359-3997 http://hdl.handle.net/11449/187698 10.20945/2359-3997000000114 S2359-39972019000200142 2-s2.0-85066163660 S2359-39972019000200142.pdf |
url |
http://dx.doi.org/10.20945/2359-3997000000114 http://hdl.handle.net/11449/187698 |
identifier_str_mv |
Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019. 2359-4292 2359-3997 10.20945/2359-3997000000114 S2359-39972019000200142 2-s2.0-85066163660 S2359-39972019000200142.pdf |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Archives of Endocrinology and Metabolism |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
142-147 application/pdf |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1822182385514446848 |
dc.identifier.doi.none.fl_str_mv |
10.20945/2359-3997000000114 |